Factors predictive for response of follicular and mantle-cell lymphoma to rituximab

Nat Clin Pract Oncol. 2006 Apr;3(4):184-5. doi: 10.1038/ncponc0457.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Mantle-Cell / drug therapy*
  • Predictive Value of Tests
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab